Published in Vaccine Weekly, October 10th, 2001
In October 2000, the Naval Medical Research Center and CEL-SCI announced that an experimental peptide, based on CEL-SCI's L.E.A.P.S. technology, induced protective immune responses against challenge from malaria-causing organisms. The data were presented by scientists from the NMRC and CEL-SCI at the 49th Annual Meeting of the American Society of Tropical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.